312 related articles for article (PubMed ID: 26787442)
1. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery.
Kim S; Lee MW; Kim TS; Song JW; Nam HS; Cho HS; Jang SJ; Ryu J; Oh DJ; Gweon DG; Park SH; Park K; Oh WY; Yoo H; Kim JW
Eur Heart J; 2016 Oct; 37(37):2833-2844. PubMed ID: 26787442
[TBL] [Abstract][Full Text] [Related]
2. Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels.
Lee S; Lee MW; Cho HS; Song JW; Nam HS; Oh DJ; Park K; Oh WY; Yoo H; Kim JW
Circ Cardiovasc Interv; 2014 Aug; 7(4):560-9. PubMed ID: 25074255
[TBL] [Abstract][Full Text] [Related]
3. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.
Verjans JW; Osborn EA; Ughi GJ; Calfon Press MA; Hamidi E; Antoniadis AP; Papafaklis MI; Conrad MF; Libby P; Stone PH; Cambria RP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1087-1095. PubMed ID: 27544892
[TBL] [Abstract][Full Text] [Related]
4. Macrophage targeted theranostic strategy for accurate detection and rapid stabilization of the inflamed high-risk plaque.
Song JW; Nam HS; Ahn JW; Park HS; Kang DO; Kim HJ; Kim YH; Han J; Choi JY; Lee SY; Kim S; Oh WY; Yoo H; Park K; Kim JW
Theranostics; 2021; 11(18):8874-8893. PubMed ID: 34522216
[No Abstract] [Full Text] [Related]
5. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques.
Vinegoni C; Botnaru I; Aikawa E; Calfon MA; Iwamoto Y; Folco EJ; Ntziachristos V; Weissleder R; Libby P; Jaffer FA
Sci Transl Med; 2011 May; 3(84):84ra45. PubMed ID: 21613624
[TBL] [Abstract][Full Text] [Related]
6. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging.
Ughi GJ; Verjans J; Fard AM; Wang H; Osborn E; Hara T; Mauskapf A; Jaffer FA; Tearney GJ
Int J Cardiovasc Imaging; 2015 Feb; 31(2):259-68. PubMed ID: 25341407
[TBL] [Abstract][Full Text] [Related]
7. Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.
Tellez A; Afari ME; Buszman PP; Seifert P; Cheng Y; Milewski K; McGregor JC; Garza JA; Roberts MB; Yi GH; Kaluza GL; Granada JF
Coron Artery Dis; 2014 Nov; 25(7):595-601. PubMed ID: 25013949
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging.
Ughi GJ; Wang H; Gerbaud E; Gardecki JA; Fard AM; Hamidi E; Vacas-Jacques P; Rosenberg M; Jaffer FA; Tearney GJ
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1304-1314. PubMed ID: 26971006
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
[TBL] [Abstract][Full Text] [Related]
10. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
11. Everolimus-eluting stents stabilize plaque inflammation in vivo: assessment by intravascular fluorescence molecular imaging.
Calfon Press MA; Mallas G; Rosenthal A; Hara T; Mauskapf A; Nudelman RN; Sheehy A; Polyakov IV; Kolodgie F; Virmani R; Guerrero JL; Ntziachristos V; Jaffer FA
Eur Heart J Cardiovasc Imaging; 2017 May; 18(5):510-518. PubMed ID: 28039209
[TBL] [Abstract][Full Text] [Related]
12. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
13. Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.
Hara T; Ughi GJ; McCarthy JR; Erdem SS; Mauskapf A; Lyon SC; Fard AM; Edelman ER; Tearney GJ; Jaffer FA
Eur Heart J; 2017 Feb; 38(6):447-455. PubMed ID: 26685129
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of intracoronary optical coherence tomography.
Regar E; Ligthart J; Bruining N; van Soest G
Herz; 2011 Aug; 36(5):417-29. PubMed ID: 21744151
[TBL] [Abstract][Full Text] [Related]
15. Intravascular Molecular Imaging: Near-Infrared Fluorescence as a New Frontier.
Khraishah H; Jaffer FA
Front Cardiovasc Med; 2020; 7():587100. PubMed ID: 33330648
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
17. [Combined use of optical coherence tomography and intravascular ultrasound during percutaneous coronary intervention in patients with coronary artery disease].
Hou JB; Meng LB; Jing SH; Han ZG; Yu H; Yu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):980-4. PubMed ID: 19102909
[TBL] [Abstract][Full Text] [Related]
18. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
19. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
20. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
